Jeremy Samuel Faust, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mortality | 7 | 2023 | 2864 | 1.410 |
Why?
|
| Amnesia, Transient Global | 2 | 2016 | 22 | 1.120 |
Why?
|
| Shock, Septic | 2 | 2021 | 775 | 0.850 |
Why?
|
| Suicide | 3 | 2021 | 1477 | 0.830 |
Why?
|
| Influenza, Human | 2 | 2020 | 1479 | 0.670 |
Why?
|
| Loneliness | 1 | 2021 | 185 | 0.660 |
Why?
|
| Homicide | 1 | 2021 | 287 | 0.640 |
Why?
|
| Social Isolation | 1 | 2021 | 365 | 0.620 |
Why?
|
| Coronavirus | 1 | 2020 | 158 | 0.600 |
Why?
|
| Periodicals as Topic | 2 | 2022 | 1432 | 0.590 |
Why?
|
| Cause of Death | 3 | 2022 | 3584 | 0.580 |
Why?
|
| Emergency Medicine | 2 | 2017 | 1207 | 0.560 |
Why?
|
| Remote Consultation | 1 | 2018 | 238 | 0.530 |
Why?
|
| Accidents, Traffic | 1 | 2021 | 819 | 0.530 |
Why?
|
| Coronavirus Infections | 4 | 2020 | 3133 | 0.520 |
Why?
|
| Education, Medical, Graduate | 2 | 2018 | 2291 | 0.520 |
Why?
|
| Pneumonia, Viral | 4 | 2020 | 3240 | 0.520 |
Why?
|
| Sepsis | 2 | 2021 | 2593 | 0.510 |
Why?
|
| Medical Staff, Hospital | 1 | 2018 | 603 | 0.480 |
Why?
|
| Primary Prevention | 1 | 2021 | 1167 | 0.470 |
Why?
|
| Pneumonia | 1 | 2023 | 2133 | 0.390 |
Why?
|
| Education, Distance | 1 | 2015 | 251 | 0.380 |
Why?
|
| Peer Review, Research | 1 | 2014 | 329 | 0.380 |
Why?
|
| Quality Indicators, Health Care | 2 | 2021 | 1831 | 0.370 |
Why?
|
| Health Status Disparities | 1 | 2021 | 1797 | 0.350 |
Why?
|
| Emergency Service, Hospital | 4 | 2017 | 7659 | 0.340 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 3047 | 0.330 |
Why?
|
| Wounds and Injuries | 1 | 2021 | 2400 | 0.330 |
Why?
|
| Education, Medical, Continuing | 1 | 2014 | 840 | 0.320 |
Why?
|
| Publishing | 1 | 2014 | 833 | 0.280 |
Why?
|
| Pandemics | 3 | 2020 | 8388 | 0.270 |
Why?
|
| Internship and Residency | 2 | 2017 | 5788 | 0.260 |
Why?
|
| Primary Health Care | 1 | 2021 | 4558 | 0.260 |
Why?
|
| Asthma | 1 | 2023 | 6011 | 0.250 |
Why?
|
| Age Distribution | 2 | 2021 | 2902 | 0.250 |
Why?
|
| Massachusetts | 3 | 2022 | 8663 | 0.250 |
Why?
|
| Humans | 33 | 2023 | 744343 | 0.230 |
Why?
|
| Medicaid | 1 | 2017 | 2736 | 0.230 |
Why?
|
| United States | 9 | 2023 | 69872 | 0.230 |
Why?
|
| Medicare | 2 | 2021 | 6566 | 0.220 |
Why?
|
| Internet | 1 | 2015 | 3064 | 0.210 |
Why?
|
| Ritonavir | 1 | 2023 | 322 | 0.200 |
Why?
|
| Pharmaceutical Services | 1 | 2023 | 140 | 0.200 |
Why?
|
| Curriculum | 1 | 2015 | 3605 | 0.200 |
Why?
|
| Pharmacy | 1 | 2023 | 91 | 0.200 |
Why?
|
| Texas | 1 | 2022 | 392 | 0.190 |
Why?
|
| Death Certificates | 1 | 2020 | 169 | 0.180 |
Why?
|
| New York City | 1 | 2020 | 710 | 0.160 |
Why?
|
| Life Expectancy | 1 | 2023 | 1184 | 0.140 |
Why?
|
| Hot Temperature | 1 | 2022 | 1354 | 0.140 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 459 | 0.140 |
Why?
|
| Adult | 8 | 2023 | 214055 | 0.140 |
Why?
|
| Disease Transmission, Infectious | 1 | 2021 | 547 | 0.130 |
Why?
|
| Buprenorphine | 1 | 2023 | 640 | 0.130 |
Why?
|
| Spinal Puncture | 1 | 2016 | 281 | 0.120 |
Why?
|
| Seasons | 1 | 2020 | 1493 | 0.120 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 857 | 0.120 |
Why?
|
| China | 1 | 2020 | 2248 | 0.120 |
Why?
|
| Workflow | 1 | 2018 | 847 | 0.120 |
Why?
|
| Age Factors | 2 | 2021 | 18370 | 0.110 |
Why?
|
| Cohort Studies | 4 | 2023 | 40561 | 0.110 |
Why?
|
| History, 20th Century | 1 | 2020 | 2740 | 0.110 |
Why?
|
| Suicidal Ideation | 1 | 2021 | 1248 | 0.100 |
Why?
|
| Disease Outbreaks | 1 | 2020 | 1772 | 0.100 |
Why?
|
| Antiviral Agents | 1 | 2023 | 2987 | 0.100 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 12959 | 0.100 |
Why?
|
| Career Choice | 1 | 2017 | 744 | 0.090 |
Why?
|
| Information Dissemination | 1 | 2018 | 1099 | 0.090 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2016 | 1018 | 0.080 |
Why?
|
| Analgesics, Opioid | 2 | 2023 | 3674 | 0.080 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 2065 | 0.080 |
Why?
|
| Forecasting | 1 | 2017 | 2951 | 0.080 |
Why?
|
| Biomedical Research | 1 | 2023 | 3309 | 0.070 |
Why?
|
| Female | 7 | 2023 | 380194 | 0.070 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 1956 | 0.070 |
Why?
|
| Prevalence | 1 | 2023 | 15226 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2021 | 5102 | 0.070 |
Why?
|
| Disease Management | 1 | 2016 | 2459 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 3610 | 0.060 |
Why?
|
| Qatar | 1 | 2023 | 36 | 0.060 |
Why?
|
| Aged | 3 | 2021 | 163280 | 0.060 |
Why?
|
| Risk Factors | 2 | 2023 | 72290 | 0.060 |
Why?
|
| Hospitalization | 1 | 2021 | 10262 | 0.050 |
Why?
|
| Pregnancy | 1 | 2022 | 29144 | 0.050 |
Why?
|
| Connecticut | 1 | 2021 | 366 | 0.050 |
Why?
|
| Male | 5 | 2023 | 350118 | 0.050 |
Why?
|
| Middle Aged | 5 | 2023 | 213383 | 0.040 |
Why?
|
| Seroepidemiologic Studies | 1 | 2021 | 401 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2023 | 77449 | 0.040 |
Why?
|
| Developed Countries | 1 | 2021 | 437 | 0.040 |
Why?
|
| Carrier State | 1 | 2021 | 518 | 0.040 |
Why?
|
| Time Factors | 1 | 2018 | 40075 | 0.040 |
Why?
|
| Young Adult | 1 | 2021 | 56430 | 0.030 |
Why?
|
| Reference Standards | 1 | 2016 | 1025 | 0.030 |
Why?
|
| Adolescent | 1 | 2021 | 85781 | 0.030 |
Why?
|
| Health Promotion | 1 | 2023 | 2205 | 0.020 |
Why?
|
| Headache | 1 | 2016 | 1226 | 0.020 |
Why?
|
| Health Personnel | 1 | 2020 | 3218 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 25043 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5319 | 0.010 |
Why?
|
| Infant | 1 | 2023 | 35136 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 23338 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 20129 | 0.010 |
Why?
|